1. Home
  2. ABSI

as of 02-20-2026 4:00pm EST

$2.65
$0.13
-4.68%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Founded: 2011 Country:
United States
United States
Employees: N/A City: VANCOUVER
Market Cap: 418.0M IPO Year: 2021
Target Price: $7.98 AVG Volume (30 days): 3.0M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.65 EPS Growth: 21.67
52 Week Low/High: $2.01 - $5.23 Next Earning Date: 01-01-0001
Revenue: $4,534,000 Revenue Growth: -20.71%
Revenue Growth (this year): 10.72% Revenue Growth (next year): 313.07%
P/E Ratio: -4.27 Index: N/A
Free Cash Flow: -72806000.0 FCF Growth: N/A

AI-Powered ABSI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 77.64%
77.64%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Absci Corporation (ABSI)

McClain Sean

Chief Executive Officer

Sell
ABSI Feb 2, 2026

Avg Cost/Share

$2.99

Shares

26,761

Total Value

$80,015.39

Owned After

8,334,567

SEC Form 4

Sell
ABSI Feb 2, 2026

Avg Cost/Share

$2.99

Shares

17,496

Total Value

$52,313.04

Owned After

383,538

SEC Form 4

Buy
ABSI Dec 5, 2025

Avg Cost/Share

$3.72

Shares

40,000

Total Value

$148,800.00

Owned After

63,320

SEC Form 4

Latest Absci Corporation News

ABSI Breaking Stock News: Dive into ABSI Ticker-Specific Updates for Smart Investing

All ABSI News

Share on Social Networks: